DiaMedica Therapeutics
DMAC
DMAC
41 hedge funds and large institutions have $52.1M invested in DiaMedica Therapeutics in 2021 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 15 increasing their positions, 8 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
1.61% less ownership
Funds ownership: 31.93% → 30.32% (-1.6%)
14% less capital invested
Capital invested by funds: $60.6M → $52.1M (-$8.48M)
Holders
41
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$672K | |
| 2 | +$608K | |
| 3 | +$579K | |
| 4 |
JAMONY
Jacob Asset Management of New York
Hermosa Beach,
California
|
+$412K |
| 5 |
Renaissance Technologies
New York
|
+$363K |
Top Sellers
| 1 | -$3.32M | |
| 2 | -$2.27M | |
| 3 | -$671K | |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$329K |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$190K |